The 20 Best Adult T-Cell Leukemia Doctors Near Me in District of Columbia, US

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Catherine Bollard is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Bollard is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Kieron Dunleavy is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Dunleavy is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Aspiration.

Anant Vatsayan, MBBS, is a blood and marrow transplant/cellular therapy attending at Children’s National Hospital. He is an assistant professor of pediatrics at the George Washington School of Medicine and Health Sciences, the cellular therapy laboratory medical director, and the pediatric BMT fellowship director for the joint NCI/Children’s National Hospital BMT Fellowship Program. He is a board-certified pediatric hematologist/oncologist. Prior to joining Children’s National, Dr. Vatsayan completed a two-year fellowship in cellular therapy/blood and marrow transplantation (BMT) at Memorial Sloan Kettering Center, New York. He did his pediatric hematology/oncology fellowship at Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, Ohio. His research interests include BMT/cellular therapies for pediatric high-risk hematologic malignancies. He is the clinical lead for the Chimeric Antigen Receptor T (CAR-T) therapy program at Children’s National. His other interests include novel transplantation techniques like TCR alpha/beta T cell depleted BMT, graft versus host disease and BMT for high-risk inherited bone marrow failure syndromes, like Fanconi anemia. Dr. Vatsayan is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. His clinical expertise encompasses Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Acquired Amegakaryocytic Thrombocytopenia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant. Dr. Vatsayan is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2013.

Hira Latif is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Latif is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, and Protein S Deficiency.

Vera Malkovska is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Malkovska is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.

Leonid Dubrovsky is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Dubrovsky is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. His clinical expertise encompasses Leukemia, Adult T-Cell Leukemia, and Immune Thrombocytopenic Purpura (ITP).